Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Sales | 12,906,000 | 13,703,000 | 13,168,000 | 12,896,000 | 12,779,000 |
Cost of Goods | 2,563,000 | 3,256,000 | 2,844,000 | 2,660,000 | 2,468,000 |
Gross Profit | 10,343,000 | 10,447,000 | 10,324,000 | 10,236,000 | 10,311,000 |
Operating Expenses | 6,394,000 | 8,140,000 | 6,660,000 | 6,495,000 | 6,301,000 |
Operating Income | 3,949,000 | 2,307,000 | 3,664,000 | 3,741,000 | 4,010,000 |
Other Income | 178,000 | -1,353,000 | -79,000 | 74,000 | -59,000 |
Pre-tax Income | 4,127,000 | 954,000 | 3,585,000 | 3,815,000 | 3,951,000 |
Income Tax | 556,000 | -11,336,000 | 727,000 | 739,000 | 821,000 |
Net Income Continuous | 3,571,000 | 12,288,000 | 2,858,000 | 3,077,000 | 3,130,000 |
Net Income Discontinuous | -1,000 | N/A | N/A | 2,000 | N/A |
Minority Interests | 9,000 | 15,000 | 18,000 | 5,000 | 9,000 |
Net Income | $3,561,000 | $12,274,000 | $2,840,000 | $3,073,000 | $3,121,000 |
EPS Basic Total Ops | 0.60 | 2.05 | 0.48 | 0.52 | 0.52 |
EPS Basic Continuous Ops | 0.60 | 2.05 | 0.48 | 0.52 | 0.52 |
EPS Diluted Total Ops | 0.59 | 2.03 | 0.47 | 0.51 | 0.51 |
EPS Diluted Continuous Ops | 0.59 | 2.03 | 0.47 | 0.51 | 0.51 |
EBITDA(a) | $5,516,000 | $3,881,000 | $5,230,000 | $5,315,000 | $5,565,000 |